Universidad de Salamanca
Salamanca, 37007, Spain
NCT Number: NCT04673539
The aim of this study is to adapt and validate the Spanish version of the Brief-BESTest in stroke patients
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Salamanca, 37007, Spain
Balance disorder is a major risk factor for falls. The population that has suffered a cerebrovascular accident (CVA) or stroke has balance disorders. Over the last few years the assessment of balance has taken on special importance, carrying out the development, adaptation and validation of various tools that assess it.
The Brief-BESTest has 6 items, it has demonstrated comparable reliability to the Mini-BESTest and potentially superior sensitivity. This version represents all dimensions based on the original BESTest theory.
The purpose is to adapt and validate the Spanish version of the Brief-BESTest in stroke patients in order to have a brief tool, appropriate to the clinical environment and to the characteristics and limitations of these patients.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Adaptation and validation of the Spanish version of the Brief-BESTest in stroke Patients
Time frame: Baseline
Time frame: Baseline
Time frame: Baseline
Time frame: Baseline
University of Salamanca
Other
Adaptation and Validation of the Spanish Version of the Brief-BESTest in Stroke Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02425345
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT05589402
Bone Diseases, Brain Diseases
Harlingen, Texas, United States
View Trial DetailsNCT06750692
Brain Diseases, Cardiovascular Diseases
Afyonkarahisar, Turkey (Türkiye)
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial Details